Toggle light / dark theme

The recipient of the world’s first Neuralink brain-chip transplant is able to control a computer mouse by thinking, the tech startup’s founder Elon Musk announced this week.

“Progress is good, and the patient seems to have made a full recovery, with no ill effects that we are aware of,” Reuters reported that Musk said in an X Spaces event on Monday. “Patient is able to move a mouse around the screen by just thinking.”

Musk added that Neuralink was trying to get the patient to click the mouse as much as possible, Reuters reported.

bigsmile yay face_with_colon_three


An engineered cardiac patch has been created that incorporates human cells with flexible electronics and a nanocomposite structure to not only replace damaged heart tissue, but also provide remote monitoring, electrical stimulation, and the release of medication on demand. Using electroactive polymers and a combination of biological and engineered parts, the patch contracts and expands just like normal human heart tissue, but regulates those actions with the precision of a finely-tuned machine.

Invented by Professor Tal Dvir and PhD student Ron Feiner of Tel Aviv University (TAU), this new breakthrough medical device is claimed by its creators to have capabilities that surpass those of human tissue alone. As such, this patch may give new hope to people such as those 25 percent on the US national waiting list that may die before a suitable transplant heart becomes available, by effectively offering a way to fix – rather than replace – their own heart.

While a veritable horde of artificial and artificially-grown hearts are on the medical horizon (such as a silicone foam version from Cornell University and Berkeley’s heart grown on a chip), the wait for such things to be fully developed and come to market doesn’t help those facing the prospect of dying in the near future. This is the area where the TAU creation may prove to be the most valuable.

Tissues take shape during development through a series of morphogenetic movements guided by local cell-scale forces. While current in vitro approaches subjecting tissues to homogenous stresses, it is currently no possible to recapitulate highly local spatially varying forces. Here we develop a method for local actuation of organoids using embedded magnetic nanoparticles. Sequential aggregation of magnetically labelled human pluripotent stem cells followed by actuation by a magnetic field produces localized magnetic clusters within the organoid. These clusters impose local mechanical forces on the surrounding tissue in response to applied global magnetic fields. We show that precise, spatially defined actuation provides short-term mechanical tissue perturbations as well as long-term cytoskeleton remodeling. We demonstrate that local magnetically-driven actuation guides asymmetric growth and proliferation, leading to enhanced patterning in human neural organoids. We show that this approach is applicable to other model systems by observing polarized patterning in paraxial mesoderm organoids upon local magnetic actuation. This versatile approach allows for local, controllable mechanical actuation in multicellular constructs, and is widely applicable to interrogate the role of local mechanotransduction in developmental and disease model systems.

The authors have declared no competing interest.

Choanoflagellates, animals’ closest relatives, have pluripotency genes, reshaping views on their evolution.


The research highlights how evolution repurposes existing genetic tools, turning them into versatile drivers of innovation. This adaptability underscores how foundational processes in unicellular organisms laid the groundwork for the development of complex life forms.

Beyond rewriting evolutionary biology, the findings could revolutionize regenerative medicine. Understanding how ancient genes enabled pluripotency offers new pathways to refine stem cell therapies and enhance cell reprogramming techniques.

For instance, synthetic versions of these genes might outperform native animal genes, opening possibilities for more efficient treatments for diseases or tissue damage.

Scientists from the Biology Centre of the Czech Academy of Sciences found forty new freshwater viruses infecting aquatic microorganisms this year. The first one, which they isolated and described in detail, was named Budvirus after the South Bohemian capital České Budějovice. It belongs to “Giant Viruses” and it infects unicellular algae called cryptophytes.

Researchers have confirmed that this virus has an important role in the ecosystem, as it controls algal bloom, helping to maintain balance in the aquatic environment. The discoveries of all the viruses were made at the Římov reservoir near České Budějovice, which has been regularly monitored by South Bohemian hydrobiologists for five decades and is one of the most studied freshwater reservoirs in Europe. The work is published in The ISME Journal.

Although we have freshwater ecosystems such as lakes, ponds, reservoirs and rivers all around us, their microscopic representatives, especially viruses and bacteria, are still a little-explored area. A drop of water can contain a million bacteria and ten times more viruses, but only a handful of them have been described. Recent methods, such as environmental DNA analysis, are making great strides in the study of the aquatic microworld. This is also one of the methods used by the Czech scientific team.

Our bodies divest themselves of 60 billion cells every day through a natural process of cell culling and turnover called apoptosis.

These cells — mainly blood and gut cells — are all replaced with new ones, but the way our bodies rid themselves of material could have profound implications for cancer therapies in a new approach developed by Stanford Medicine researchers.

They aim to use this natural method of cell death to trick cancer cells into disposing of themselves. Their method accomplishes this by artificially bringing together two proteins in such a way that the new compound switches on a set of cell death genes, ultimately driving tumor cells to turn on themselves. The researchers describe their latest such compound in a paper published Oct. 4 in Science.